WallStreetZenWallStreetZen

NASDAQ: CELU
Celularity Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their CELU stock forecasts and price targets.

Forecast return on equity

Is CELU forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is CELU forecast to generate an efficient return on assets?

Company
-75.65%
Industry
-23.83%
CELU is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CELU earnings per share forecast

What is CELU's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$2.81

CELU revenue forecast

What is CELU's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$44.9M+69.04%

CELU vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CELU$0.91N/AN/A
JSPR$0.91$4.17+358.92%Hold
DYAI$0.75N/AN/A
BRNS$0.67$4.00+497.01%Buy
AIXC$1.38N/AN/A
View Top Biotech Stocks

Celularity Stock Forecast FAQ

What is CELU's earnings growth forecast for 2026-2026?

(NASDAQ: CELU) Celularity's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Celularity's earnings in 2026 is -$91,800,000.

In 2026, CELU is forecast to generate -$81,193,421 in earnings, with the lowest earnings forecast at -$78,009,365 and the highest earnings forecast at -$83,581,462.

If you're new to stock investing, here's how to buy Celularity stock.

What is CELU's revenue growth forecast for 2026-2026?

(NASDAQ: CELU) Celularity's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Celularity's revenue in 2026 is $26,550,000.

In 2026, CELU is forecast to generate $1,299,094,730 in revenue, with the lowest revenue forecast at $1,248,149,838 and the highest revenue forecast at $1,337,303,398.

What is CELU's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: CELU) forecast ROA is -75.65%, which is lower than the forecast US Biotechnology industry average of -23.83%.

What is CELU's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: CELU) Celularity's current Earnings Per Share (EPS) is -$3.59. In 2026, CELU's EPS is forecast to hit -$2.81 (min: -$2.70, max: -$2.89).

What is CELU's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: CELU) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.